The school year is officially in full swing, and so is the school-day routine. Backpacks are filled with homework assignments, lunches are packed and it’s your day for the carpool. Just because you’ve established a routine, it doesn’t necessarily mean that all is smooth-sailing.
Eleven percent (6 million)[i] of school-aged children across the United States have Attention Deficit Hyperactivity Disorder (ADHD) and for many parents, the first parent/teacher conference of the school year is a critical time to ensure their child is off to a good start and getting the right support. The parent/teacher conference can help you better understand how your child is performing in school, and could be key in identifying whether the current ADHD treatment plan and routine you have established are actually working, or if it’s time to reassess.
Children with ADHD exhibit symptoms of inattention, impulsivity and/or hyperactivity. Although any child can have moments displaying any of these symptoms, children with ADHD experience combinations of all three repeatedly and in a way that is severe enough to have an impact at home, school, or in social situations. Common behaviors children with ADHD may exhibit at school include squirming or fidgeting in seat, trouble taking turns, daydreaming often, talking too much and making careless mistakes.[ii]
If you are a parent of a child with ADHD, use the following tips from Dr. Richard Winer, a psychiatrist at North Fulton Psychiatric Care in Roswell, Georgia, to prepare for your child’s upcoming parent/teacher conference:
- Note any observations you’ve noticed about your child’s behavior at home, and prepare to discuss them with your child’s teacher: Does your child have trouble organizing him or herself when they get home from school? Do they avoid tasks that require focus, such as completing homework? Do they have a hard time sitting still or being patient? It is important to acknowledge if your child displays these types of behaviors at home and speak with his or her teacher to see if they display them in the classroom as well.
- Come to the school conference with questions for the teacher already prepared: Create a list of questions you’d like to ask your child’s teacher. For example, is my child having trouble focusing during the day or do they often interrupt class? Is my child completing classwork? If so, how long does it take him or her? Is my child following instructions? Asking these questions will help to better understand if your child’s ADHD treatment might need to be reassessed.
- Be prepared to take notes: Your child isn’t the only one who needs paper and a pencil! Bring a notepad to take down key points you and your child’s teacher discuss. You may find some of the examples your teacher shares to be especially relevant at the next appointment with your child’s pediatrician or psychiatrist.
- Use the information you gathered to talk about ADHD treatment options with your doctor: Once you’ve discussed your child’s progress and challenges with their teacher, don’t wait to set up a doctor’s appointment. Your doctor might be able to help you assess or reassess your child’s ADHD medications and you might learn about treatment options you didn’t know about yet.
For example, I’ve been working with Neos Therapeutics to tell people about Adzenys XR-ODT™, an extended-release orally disintegrating tablet that dissolves in the mouth and is swallowed. Adzenys XR-ODT is approved for patients with ADHD ages six and above. All ADHD stimulants are federally controlled substances that can be abused or lead to dependence, so parents should keep Adzenys XR-ODT in a safe place to prevent misuse and abuse and remember that it should not be sold or given away. Parents should work closely with their doctors to understand potential risks and visit AdzenysXRODT.com for more information.
More information about ADHD is also available on the Centers for Disease Control and Children and Adults with Attention-Deficit/Hyperactivity Disorder’s (CHADD) websites.
Important Safety Information
Adzenys XR-ODT is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Adzenys XR-ODT in a safe place to prevent misuse and abuse. Selling or giving away Adzenys XR-ODT may harm others and is against the law.
Tell your doctor if you or your child has ever abused or been dependent on alcohol, prescription medicines, or street drugs.
Who should not take Adzenys XR-ODT?
Do not take Adzenys XR-ODT if you or your child is:
- allergic to amphetamine or any ingredients in Adzenys XR-ODT.
- taking or has taken an anti-depression medicine called monoamine oxidase inhibitor (MAOI) within the past 14 days.
Adzenys XR-ODT is a stimulant medicine. Tell your doctor about health conditions, including if:
- you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems. This is important because sudden death has occurred in people with heart problems or defects, and sudden death, stroke and heart attack have happened in adults. Your doctor should check for heart problems prior to prescribing Adzenys XR-ODT and will check you or your child’s blood pressure and heart rate during treatment. Call the doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while taking Adzenys XR-ODT.
- you or your child has mental problems, or a family history of suicide, bipolar illness, or depression. This is important because the following could occur: new or worse behavior and thought problems, new or worse bipolar illness, new psychotic symptoms (hearing voices, believing things that are not true, are suspicious) or new manic symptoms. Call the doctor right away if there are any new or worsening mental symptoms during treatment.
- you or your child has circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color from pale, to blue, to red. Call the doctor right away if any signs of unexplained wounds appear on fingers or toes while taking Adzenys XR-ODT.
- your child is having slowing of growth (height and weight). Your child should have his or her height and weight checked often while taking Adzenys XR-ODT. The doctor may stop treatment if a problem is found during these check-ups.
- you or your child has kidney problems. Your doctor may lower the dose.
- you or your child is, or plans to become pregnant.
- you or your child is breastfeeding, or plans to breastfeed. You should not breastfeed while taking Adzenys XR-ODT.
- you or your child takes any medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Adzenys XR-ODT and some medicines may interact with each other and cause serious side effects.
Do not start any new medicine while taking Adzenys XR-ODT without talking to your doctor first.
What should I avoid while taking Adzenys XR-ODT?
Common side effects of Adzenys XR-ODT include:
- Decreased appetite and problems sleeping.
- Children 6 – 12 Years also include: Stomach pain, extreme mood change, vomiting, nervousness, nausea, and fever.
- Children 13 – 17 Years also include: Stomach pain and weight loss.
- Adults also include: Dry mouth, headache, weight loss, nausea, anxiety, restlessness, dizziness, fast heart beat, diarrhea, weakness, and urinary tract infections.
These are not all the possible side effects of Adzenys XR-ODT. Call your doctor for medical advice about side effects.
What is Adzenys XR-ODT?
Adzenys XR-ODT is a prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and above.
For additional safety information, click here for Prescribing Information and Medication Guide and discuss with your doctor.
To report suspected adverse reactions, contact Neos Therapeutics, Inc. at 1-888-219-1789. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Adzenys XR-ODT™ is a trademark of Neos Therapeutics. ©2016 Neos Therapeutics Inc. All rights reserved.
[i] Centers for Disease Control and Prevention. ADHD Data & Statistics. CDC.gov website. http://www.cdc.gov/ncbddd/adhd/data.html. Accessed July 6, 2016.
[ii] Centers for Disease Control and Prevention. Facts About ADHD. CDC.gov website. http://www.cdc.gov/ncbddd/adhd/facts.html. Accessed August 25, 2016.